Targeting NDRG1 to inhibit bidirectional oncogenic cross-talk between pancreatic cancer and stroma

被引：0
|
作者：
Geleta, Bekesho [1 ]
Park, Kyung Chan [2 ]
Jansson, Patric J. [2 ]
Sahni, Sumit [2 ]
Apte, Minoti [3 ]
Richardson, Des [4 ]
Kovacevic, Zaklina [2 ]
机构：
[1] Childrens Canc Inst, Kensington, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Ingham Inst Appl Med Res, Liverpool, Merseyside, England
[4] Griffith Univ, Nathan, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma
    Geleta, Bekesho
    Park, Kyung Chan
    Jansson, Patric J.
    Sahni, Sumit
    Maleki, Sanaz
    Xu, Zhihong
    Murakami, Takashi
    Pajic, Marina
    Apte, Minoti, V
    Richardson, Des R.
    Kovacevic, Zaklina
    [J]. FASEB JOURNAL, 2021, 35 (02):
  • [2] A novel therapeutic approach to inhibit the bidirectional oncogenic crosstalk between pancreatic cancer cells and the surrounding stroma
    Geleta, Bekesho
    Park, Kyung Chan
    Jansson, Patric J.
    Apte, Minoti
    Richardson, Des R.
    Kovacevic, Zaklina
    [J]. CANCER RESEARCH, 2019, 79 (24)
  • [3] Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1
    Geleta, Bekesho R.
    Tout, Faten
    Lim, Syer Choon
    Sahni, Sumit
    Jansson, Patric J.
    Apte, Minoti V.
    Richardson, Des R.
    Kovacevic, Zaklina
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)
  • [4] Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Interfering Cross-Talk Between Tumor and Stroma
    Qin, T.
    Wang, Z.
    Ma, Q. Y.
    [J]. PANCREAS, 2019, 48 (10) : 1510 - 1510
  • [5] Targeting the Metastasis Suppressor NDRG1: A New Strategy for the Treatment of Pancreatic Cancer
    Kovacevic, Z.
    Chikhani, S.
    Sivagurunathan, S.
    Lovejoy, D. B.
    Richardson, D. R.
    [J]. PANCREAS, 2011, 40 (08) : 1331 - 1331
  • [6] Targeting the Metastasis Suppressor NDRG1: A New Strategy for the Treatment of Pancreatic Cancer
    Richardson, Des R.
    Chikhani, Sherin
    Lui, Goldie
    Sivagurunathan, Sutharshani
    Kovacevic, Zaklina
    [J]. FASEB JOURNAL, 2012, 26
  • [7] Targeting FGFR signaling to disrupt cellular cross-talk in pancreatic cancer
    Coetzee, Abigail
    Carter, Edward
    Heward, James
    Mardakheh, Faraz
    Grose, Richard
    Kocher, Hemant
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism
    Arruabarrena-Aristorena, Amaia
    Zabala-Letona, Amaia
    Carracedo, Arkaitz
    [J]. SCIENCE ADVANCES, 2018, 4 (01):
  • [9] Exploiting cross-talk between lipid metabolism and oncogenic signaling for treatment of ovarian cancer
    Wagner, R.
    Stuebiger, G.
    Lanzerstorfer, P.
    Weghuber, J.
    Karteris, E.
    Nowikovsky, K.
    Wilfinger, N.
    Colomer, R.
    Lopez-Rodriguez, M. L.
    Grunt, T. W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S61 - S61
  • [10] Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer
    Park, Kyung Chan
    Paluncic, Jasmina
    Kovacevic, Zaklina
    Richardson, Des R.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2020, 157 : 154 - 175
12345